Cargando…
Treatment of multiple synchronous canine mast cell tumours using intratumoural tigilanol tiglate
Mast cell tumours (MCTs) are common canine skin neoplasia. While they generally occur as single tumours, multiple synchronous MCTs (msMCTs) of de novo/non-metastatic origin are reported in a proportion of the patient population. Where there is no evidence of metastasis or lymphatic spread, MCTs are...
Autores principales: | Brown, Graham K., Finlay, Jessica R., Straw, Rodney C., Ziea, Joy Y., Leung, Becky, O'Connell, Kathleen, Thomson, Maurine J., Campbell, Justine E., Jones, Pamela D., Reddell, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643212/ https://www.ncbi.nlm.nih.gov/pubmed/36387404 http://dx.doi.org/10.3389/fvets.2022.1003165 |
Ejemplares similares
-
Intratumoural Treatment of 18 Cytologically Diagnosed Canine High-Grade Mast Cell Tumours With Tigilanol Tiglate
por: Brown, Graham K., et al.
Publicado: (2021) -
Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses
por: De Ridder, Thomas, et al.
Publicado: (2020) -
Tigilanol Tiglate-Mediated Margins: A Comparison With Surgical Margins in Successful Treatment of Canine Mast Cell Tumours
por: De Ridder, Thomas, et al.
Publicado: (2021) -
Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors
por: Miller, Jane, et al.
Publicado: (2019) -
Identification of Gene Biomarkers for Tigilanol Tiglate Content in Fontainea picrosperma
por: Mitu, Shahida A, et al.
Publicado: (2022)